Hanson & Doremus Investment Management Sells 446 Shares of iShares Biotechnology ETF (NASDAQ:IBB)
Hanson & Doremus Investment Management lessened its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 9.3% during the third quarter, Holdings Channel reports. The institutional investor owned 4,362 shares of the financial services provider’s stock after selling 446 shares during the quarter. Hanson & Doremus Investment Management’s holdings in iShares Biotechnology […]